{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:58:19Z","timestamp":1780649899149,"version":"3.54.1"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2011,2,28]],"date-time":"2011-02-28T00:00:00Z","timestamp":1298851200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017297","type":"journal-article","created":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T20:22:54Z","timestamp":1299010974000},"page":"e17297","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["A Rapid Flp-In System for Expression of Secreted H5N1 Influenza Hemagglutinin Vaccine Immunogen in Mammalian Cells"],"prefix":"10.1371","volume":"6","author":[{"given":"Hanxin","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Manischewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Beigel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Golding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,2,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa055778","article-title":"Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.","volume":"354","author":"JJ Treanor","year":"2006","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.1093373","article-title":"Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus.","volume":"303","author":"J Stevens","year":"2004","journal-title":"Science"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1128\/JVI.00187-08","article-title":"Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus.","volume":"82","author":"CJ Wei","year":"2008","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nmeth.f.202","article-title":"Protein production and purification.","volume":"5","author":"S Graslund","year":"2008","journal-title":"Nat Methods"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"10366","DOI":"10.1128\/JVI.01035-10","article-title":"Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets.","volume":"84","author":"BJ Bosch","journal-title":"J Virol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/174.4.838","article-title":"Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults.","volume":"174","author":"DL Lakey","year":"1996","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.vaccine.2005.11.005","article-title":"Expression and purification of an influenza hemagglutinin\u2013one step closer to a recombinant protein-based influenza vaccine.","volume":"24","author":"K Wang","year":"2006","journal-title":"Vaccine"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jim.2007.01.022","article-title":"An efficient and targeted gene integration system for high-level antibody expression.","volume":"322","author":"Y Huang","year":"2007","journal-title":"J Immunol Methods"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/bit.20865","article-title":"Production of target-specific recombinant human polyclonal antibodies in mammalian cells.","volume":"94","author":"FC Wiberg","year":"2006","journal-title":"Biotechnol Bioeng"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5305","DOI":"10.1016\/j.febslet.2005.08.056","article-title":"Differences between human proteinase 3 and neutrophil elastase and their murine homologues are relevant for murine model experiments.","volume":"579","author":"O Wiesner","year":"2005","journal-title":"FEBS Lett"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4049\/jimmunol.0903887","article-title":"Mapping of conformational epitopes on human proteinase 3, the autoantigen of Wegener&apos;s granulomatosis.","volume":"185","author":"A Kuhl","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1000049","DOI":"10.1371\/journal.pmed.1000049","article-title":"Antigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targets.","volume":"6","author":"S Khurana","year":"2009","journal-title":"PLoS Med"},{"key":"ref13","first-page":"15ra15","article-title":"Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.","volume":"2","author":"S Khurana","journal-title":"Sci Transl Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1086\/599992","article-title":"Safety and immunogenicity of multiple and higher doses of an inactivated influenza A\/H5N1 vaccine.","volume":"200","author":"JH Beigel","year":"2009","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1086\/527489","article-title":"Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults.","volume":"197","author":"DI Bernstein","year":"2008","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.1016\/j.vaccine.2010.06.065","article-title":"Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.","volume":"28","author":"A Carmona","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1056\/NEJMc0805274","article-title":"Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1.","volume":"359","author":"I Stephenson","year":"2008","journal-title":"N Engl J Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.copbio.2009.10.008","article-title":"Expression systems for therapeutic glycoprotein production.","volume":"20","author":"Y Durocher","year":"2009","journal-title":"Curr Opin Biotechnol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.virol.2009.09.017","article-title":"The influence of the multi-basic cleavage site of the H5 hemagglutinin on the attenuation, immunogenicity and efficacy of a live attenuated influenza A H5N1 cold-adapted vaccine virus.","volume":"395","author":"AL Suguitan Jr","year":"2009","journal-title":"Virology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"e10645","DOI":"10.1371\/journal.pone.0010645","article-title":"A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1.","volume":"5","author":"LA Cornelissen","year":"2010","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cimid.2007.07.004","article-title":"Influenza vaccines and vaccination strategies in birds.","volume":"31","author":"T van den Berg","year":"2008","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1637\/7628-042806R.1","article-title":"Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge.","volume":"51","author":"M Steensels","year":"2007","journal-title":"Avian Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"11374","DOI":"10.1128\/JVI.01176-08","article-title":"Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks.","volume":"82","author":"JK Kim","year":"2008","journal-title":"J Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:36:31Z","timestamp":1589027791000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017297"}},"subtitle":[],"editor":[{"given":"Ralph","family":"Tripp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,2,28]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,2,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017297","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,28]]}}}